SENORES — Senores Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹51.16bn
- IN₹51.18bn
- IN₹6.33bn
Annual cashflow statement for Senores Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 11.4 | 124 | 249 | 706 | 1,591 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.43 | 6.72 | -0.7 | -77.9 | 45.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -123 | -160 | -607 | -1,255 | -1,344 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -104 | -10.8 | -257 | -459 | 621 |
| Capital Expenditures | -107 | -473 | -518 | -1,575 | -2,647 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -138 | -10.1 | -24 | -2,720 | 1,442 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -244 | -483 | -542 | -4,295 | -1,206 |
| Financing Cash Flow Items | 211 | -14.1 | -98.5 | 4,358 | -33.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 365 | 463 | 870 | 5,731 | -13.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.8 | -31.1 | 70.5 | 977 | -598 |